Global $12.2 Bn Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market to 2025

DUBLIN, Aug 20, 2018 /PRNewswire/ --

The "Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size, Share & Trends Analysis Report By Procedure (Transapical, Transfemoral, Transaortic), By Country, Vendor Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global transcatheter aortic valve replacement (TAVR) devices market size is anticipated to reach USD 12.2 billion by 2025, progressing at a CAGR of 22.6% during the forecast period.

Increasing incidence of cardiovascular diseases and severe aortic stenosis disorder are among key factors augmenting the TAVR device market. Moreover, rising number of various clinical trials such as Edwards SAPIEN 3 and Medtronic Transcatheter Aortic Valve 2.0 Replacement System are likely to contribute to the growth of the market during the forecast period.

Improvements in surgical techniques and quality of implantable valves are leading to an increase in the adoption of aortic valve replacement procedures. Moreover, surging demand for minimally invasive surgeries as compared to traditional open heart procedures, availability of reimbursement for surgical procedures, and growing inclination of physicians towards TAVR procedures are projected to boost the growth of the market.

Launch of new devices with advanced technology for fast and effective treatment is poised to propel the market. For instance, in April 2016, St. Jude Medical launched a new device - Trifecta Valve with glide technology to be used in both conventional as well as minimally invasive procedures.

Further key findings from the report suggest:

• The global Transcatheter Aortic Valve Implantation (TAVI) procedures market size is anticipated to reach USD 26.3 billion by 2025
• Transcatheter aortic valve implantation procedure is a feasible alternative to conventional by-pass surgery because of its minimally invasive nature and has lower risk of complications. Owing to its advantage, the demand for TAVR is expected to tread along a healthy growth track
• Transfemoral implantation accounted for the largest share in the market in 2017 as it is a minimally invasive procedure, which reduces the time of recovery and subsequently, hospitalization costs
• Transapical implantation is estimated to be the fastest growing segment during the forecast period owing to its ease of use and lesser complications than other implantation procedures. This procedure facilitates easy entry for device with any diameter providing better tissue longevity.
• Based on country, the U.S. dominated the market and is anticipated to retain its dominance during the forecast period due to increasing number of advanced surgical methods and rising incidence of cardiovascular diseases. According to American College of Cardiology Foundation, in 2017, more than 90 million Americans were diagnosed by CVD and 800,000 deaths were reported in the U.S.
• Italy is likely to witness considerable growth due to increase in awareness of minimally invasive procedures over traditional methods and rise in healthcare expenditure along with improvement in healthcare infrastructure
• Some of the key players in the market are Medtronic plc; Boston Scientific Corporation; Meril Life Sciences Pvt. Ltd., Inc.; Edwards Lifesciences Corporation; St. Jude Medical, Inc.; JenaValve Technology, Inc.; Bracco SpA; and Transcatheter Technologies GmbH.

Key Topics Covered:

Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Market Definitions
2.1 Objective

Chapter 3 Research Methodology
3.1 Information Procurement
3.2 Data Analysis
3.3 List of Secondary Sources
3.4 List of Primary Sources

Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation and Scope
4.1.1 Market driver analysis
4.1.1.1 Impact analysis mapped against actual market growth
4.1.1.2 Increasing incidence of cardiovascular diseases
4.1.1.3 Technological advancements
4.1.1.4 Increasing demand for minimally invasive surgeries
4.1.2 Market restraint analysis
4.1.2.1 High cost
4.1.2.2 Product recall
4.2 Penetration & Growth Prospects Mapping
4.3 Transcatheter Aortic Valve Replacement (TAVR) Market - PESTLE Analysis
4.4 Industry Analysis - Porter's
4.5 Transcatheter Aortic Valve Replacement (TAVR) Competitive Landscape: Market Position Analysis (Based on Procedure, Device, Regional Presence, and Recent Updates)

Chapter 5 Regulatory Framework
5.1 Transcatheter Aortic Valve Replacement (TAVR) Regulations in the U.S.
5.2 Transcatheter Aortic Valve Replacement (TAVR) Regulations in France
5.3 Transcatheter Aortic Valve Replacement (TAVR) Regulations in Germany
5.4 Transcatheter Aortic Valve Replacement (TAVR) Regulations in U.K.
5.5 Transcatheter Aortic Valve Replacement (TAVR) Regulations in Japan

Chapter 6 Transcatheter Aortic Valve Replacement (TAVR) Market: By Procedure Estimates & Trend Analysis
6.1 Transcatheter Aortic Valve Replacement (TAVR) Market: Procedure Analysis
6.2 Transfemoral Implantation
6.3 Transapical Implantation
6.4 Transaortic Implantation

Chapter 7 Transcatheter Aortic Valve Replacement (TAVR) Market: By Device Estimates & Trend Analysis

Chapter 8 Transcatheter Aortic Valve Replacement (TAVR) Market: Regional Estimates & Trend Analysis

Chapter 9 Competitive Landscape

• Medtronic plc
• Boston Scientific Corporation
• Meril Life Sciences Pvt. Ltd., Inc.
• Edwards Lifesciences Corporation
• St. Jude Medical, Inc.
• JenaValve Technology, Inc.
• Bracco SpA
• Transcatheter Technologies GmbH
• Abbott

For more information about this report visit https://www.researchandmarkets.com/research/l5kd2v/global_12_2_bn?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-12-2-bn-transcatheter-aortic-valve-replacementimplantation-tavrtavi-market-to-2025--300699322.html

SOURCE Research and Markets